Why Pfizer Stock Slipped Today
Pharmaceutical giant (NYSE: PFE) wasn't looking very tall or strong on the stock exchange Tuesday. The company's share price dipped by nearly 2% over the course of the trading session following a pair of analyst price-target cuts. Meanwhile, the bellwether S 500 index basically traded flat on the day.
Two pundits tracking Pfizer reduced their fair-value estimations on the stock. Of the pair of price-target cuts, one was drastic and the other modest.
The former came from Truist Financial's Robyn Karnauskas, who took an axe to her level, reducing it to $42 per share from the preceding $62. Despite that deep cut, she's still positive on Pfizer's future, as she maintained her buy recommendation.
Source Fool.com
Pfizer Inc. Stock
The stock is one of the favorites of our community with 31 Buy predictions and 4 Sell predictions.
As a result the target price of 41 € shows a very positive potential of 59.29% compared to the current price of 25.74 € for Pfizer Inc..